Skip to main content
. 2021 Jan 11;14:540669. doi: 10.3389/fncel.2020.540669

Figure 2.

Figure 2

Caspase-1 inhibitor vx-765 reduced cerebral infarct volume and improved neurological deficits in rats following MCAO. (A–C) Neurological deficit scores estimated using Garcia scores, forelimb placing scores, and time of rod from 6 h to day 3 after MCAO. n = 35 per group. (D) 2,3,5-Triphenyltetrazolium Chloride (TTC) staining of the infarct area at day 3 after MCAO. (E) Corresponding statistical analyses of the infarct area. Scale bar = 2 mm, n = 3 per group. Data are shown as means ± SEM, *P < 0.05 and **P < 0.01, vs. sham; #P < 0.05 and ##P < 0.01, vs. vehicle.